TAIPEI (Taiwan News) — Taiwan is intensifying efforts in generic drug development to strengthen the global competitiveness of its pharmaceutical industry, with 11 local firms currently participating ...

The US Food and Drug Administration (FDA) is committed to helping facilitate American patients’ access to lower-cost generic medicines by taking steps to enhance and streamline the development and ...

The US FDA Commissioner Scott Gottlieb announced new steps aimed at speeding up the process of reviewing generic drug marketing application and boosting competition. In a statement, the FDA regulator ...

The Generic Drugs Market has emerged as one of the most critical segments of the global pharmaceutical industry due to its ability to provide affordable and effective alternatives to branded ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The government has initiated a sweeping overhaul of the drug pricing system to lower the prices of generic drugs, which have been criticized for being more expensive than international standards. The ...

(MENAFN- GlobeNewsWire - Nasdaq) The global generic drug CRO market size was valued at USD 8.45 billion in 2024 and is predicted to hit around USD 11.73 billion by 2034, rising at a 3.36% CAGR, a ...

Viatris Inc. (NASDAQ:VTRS), a prominent player in the biopharmaceutical industry with a market capitalization of $9.73 billion, finds itself navigating a complex landscape of challenges and ...